Surrozen, Inc.

Historical 13F Holders

Symbol
SRZN
CUSIP
86889P208
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 86889P208 since 12/18/2024, largest first.

Filer % of Class Filed
Column Group III GP, LP 13D/A
18.2% 11/18/2026
Event 11/16/2026
Column Group IV GP, LP 13D
11.6% 2/12/2026
Event 2/6/2026
Boxer Capital Management, LLC 13G/A
11.6% 10/7/2026
Event 9/30/2026
AI Biotechnology LLC 13G/A
9.9% 11/20/2026
Event 11/16/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
9.9% 5/15/2026
Event 3/31/2026
RA Capital Management, L.P. 13G/A
9.2% 2/17/2026
Event 12/31/2025
Commodore Capital LP 13G
7.5% 10/1/2026
Event 9/24/2026
Point72 Asset Management, L.P. 13G/A
6.9% 11/16/2026
Event 9/30/2026
Balyasny Asset Management L.P. 13G
5.6% 11/16/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (12)
Regents of the University of California 13G 4.2% 1/28/2025
Event 12/31/2024
5AM Partners VII, LLC 13G/A
3.9% 11/16/2026
Event 9/30/2026
Braidwell LP 13G/A
3.9% 8/14/2026
Event 6/30/2026
Stonepine Capital Management, LLC 13G/A
3.6% 2/13/2026
Event 12/31/2025
StemPoint Capital LP 13G/A
3.5% 11/16/2026
Event 9/30/2026
Integrated Core Strategies (US) LLC 13G/A
3.2% 11/13/2026
Event 9/30/2026
Nantahala Capital Partners Limited Partnership 13G/A 2.2% 5/15/2025
Event 3/31/2025
Nantahala Capital Management, LLC 13G/A
2.1% 5/15/2026
Event 3/31/2026
Perceptive Advisors LLC 13G/A
1.9% 5/15/2025
Event 3/31/2025
Alyeska Investment Group, L.P. 13G/A
0.8% 2/14/2025
Event 12/31/2024
Driehaus Capital Management LLC 13G/A 0.8% 8/14/2025
Event 6/30/2025
TCG Crossover GP II, LLC 13G/A
0% 11/16/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 92 15.7 M $484M
2026 Q2 69 10.3 M $265M
2026 Q1 58 9.32 M $270M
2025 Q4 54 7.14 M $153M
2025 Q3 35 4.84 M $62.4M
2025 Q2 31 4.53 M $40.5M
2025 Q1 30 3.95 M $46.0M
2024 Q4 24 1.66 M $23.8M
2024 Q3 23 1.32 M $15.8M
2024 Q2 21 1.30 M $14.2M
2024 Q1 16 341 k $5.31M
2023 Q4 17 412 k $3.88M